MedTrace Logo

The Effect of Prenatal Education on Primary Cesarean Rate

NCT06844188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-11-25

No results posted yet for this study

Summary

This is a prospective case-control study examining the impact of antenatal education on mode of delivery. The study will include all deliveries occurring between January 2024 and December 2024. Participants will be divided into two groups: a case group consisting of women who attended antenatal classes (pregnancy school) and a control group of women who did not. The primary outcome will be mode of delivery (vaginal or cesarean).

The study will collect data on gravida and parity. Participants will be further categorized into four groups based on their delivery history:

Women undergoing a cesarean section for their first delivery. Women experiencing a normal vaginal delivery for their first delivery. Women with a history of vaginal delivery who have another vaginal delivery in this pregnancy.

Women with a history of vaginal delivery who deliver via cesarean section in this pregnancy.

Each of these four groups will have a corresponding case (antenatal class attendees) and control (non-attendees) subgroup.

Data on cesarean section indications, the name of the physician performing the cesarean, and the hospital's annual primary cesarean section rates will be requested from the hospital and compared across groups. For the case group, information regarding the specific antenatal education received, the gestational week at which the education was received, and patient characteristics such as age, infant birth weight, and educational level will also be collected.

Conditions

  • Prenatal Care Late
  • Cesarean Delivery Affecting Fetus

Sponsors & Collaborators

  • Sanliurfa Education and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Alev esercan, M.D. · Sanliurfa Education and Research Hospital

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-20
Primary Completion
2025-07-01
Completion
2025-07-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06844188 on ClinicalTrials.gov